Brunswick Group has hired Tanisha Carino, who has more than 20 years of healthcare and life sciences experience, as a partner in its Washington office.
She served as executive VP & chief corporate affairs officer at Alexion Pharmaceuticals, which was an independent Fortune 500 biotechnology company focused on rare diseases.
Carino handled global PR, policy and alliance development at Alexion. She also guided the company's communications through its acquisition by AstraZeneca.
Earlier, she was executive director of the Milken Institute's FasterCure operation, VP-US public policy at GlaxoSmithKline and head of life sciences strategic advisory services at Avalere Health.
Most recently, Carino was a visiting fellow at the White House Office of Science and Technology Policy, working in the area of pandemic preparedness.